Table 4.
Laboratory and coagulative parameters in patients with and without VTE
| Parameters | No VTE | VTE | P value |
|---|---|---|---|
| Hemoglobin, g/L | 117.8 ± 15.8 | 112.6 ± 16.5 | 0.16 |
| Platelets, ×109/L | 250.9 ± 83.2 | 262.1 ± 129.2 | 0.66 |
| Hematocrit, % | 35.6 ± 4.6 | 34.9 ± 4.7 | 0.53 |
| AST, U/L | 39.0 [18–58] | 41.0 [25–59.5] | 0.73 |
| ALT, U/L | 31.0 [25–51] | 38.0 [28–67.5] | 0.27 |
| Creatinine, µmol/L | 67.4 ± 43.6 | 86.8 ± 94.7 | 0.27 |
| PT, % | 92.7 ± 18.3 | 87.1 ± 15.7 | 0.19 |
| INR | 1.2 ± 0.3 | 1.1 ± 0.1 | 0.49 |
| aPTT, seconds | 23.7 ± 7.4 | 23.0 ± 7.5 | 0.69 |
| D‐dimer, μg/L | 259 [150–934] | 1310 [577–2485] | 0.001 |
| Fibrinogen, g/L | 5.0 [3.5–5.6] | 4.9 [3.9–5.7] | 0.73 |
| Antithrombin, % | 95.7 ± 21.3 | 92.6 ± 21.0 | 0.58 |
| MCF INTEM, mm | 68.9 ± 5.8 | 71.9 ± 5.8 | 0.13 |
| MCF EXTEM, mm | 72.3 ± 6.3 | 72.1 ± 11.1 | 0.97 |
| MCF FIBTEM, mm | 31.1 ± 9.9 | 35.0 ± 7.9 | 0.19 |
Data are expressed as mean ± SD or median and [range interquartile] as appropriate.
ALT, alanine aminotransferase; aPTT, activated partial thromboplastin time; AST, aspartate aminotransferase; INR, international normalized ratio; MCF, maximum clot firmness; PT, prothrombin time; VTE, venous thromboembolism.